Patent & IP news for April 3, 2013

Patent Litigations

USPTO Stats

6,950
published
appl'ns
5,852
granted
patents
64
ptab
decisions

Patent & IP Blogs

post image Asian Subsidiaries Royalty Rising from ipfinance.blogspot.com

The London Financial Times has an interesting story today about rises in the royalty rates that Asian subsidiaries are expected to pay to their parent companies. Apparently a number of investment funds have been gaining ...

Share via E–mail | Twitter | Facebook

post image Timing of First Actions on the Merits from www.patentlyo.com

By Dennis Crouch The chart below is a bit confusing, but I think that it presents some interesting data. The chart generally shows the timing of first actions on the merits (FAOMs). Most commonly a ...

Share via E–mail | Twitter | Facebook

Genome Medicine Article Calls for Limits on Patenting of Existing Nucleotide Sequences from www.patentdocs.org

By Donald Zuhn -- In an article published in the current issue of Genome Medicine, Jeffrey Rosenfeld of the University of Medicine & Dentistry of New Jersey and Christopher Mason of Cornell University contend that due to ...

Share via E–mail | Twitter | Facebook

A Primer on Paragraph IV Certifications: Into the Belly of the Hatch-Waxman Beast Part 1 from www.ipwatchdog.com

In a moment of extreme weakness, I agreed to Gene’s request to doing a primer on Paragraph IV Certifications under the Drug Price Competition and Patent Term Restoration Act, commonly referred to as Hatch-Waxman ...

Share via E–mail | Twitter | Facebook

Guest Post: The Patent Failure of Novartis with Gleevec from www.patentlyo.com

Guest Post by Srividhya Ragavan (Professor of Law, University of Oklahoma College of Law) The Indian Supreme Court's verdict on the Novartis patent application has garnered a lot of attention as having set a ...

Share via E–mail | Twitter | Facebook

Predicting Patent Issuance from www.patentlyo.com

By Dennis Crouch One of my patent law students (Marriam Lin) is working on a project that divides patent applications into two sets: (1) Those that are patented and (2) those that are abandoned without ...

Share via E–mail | Twitter | Facebook

ALJ Pender Issues Public Version Of Recommended Determination On Remedy And Bond In Certain Dimmable Compact Fluorescent Lamps (337-TA-830) from www.itcblog.com

On March 26, 2013, ALJ Thomas B. Pender issued the public version (dated March 1, 2013) of the Recommended Determination On Remedy And Bond (“RD”) in Certain Dimmable Compact Fluorescent Lamps and Products Containing Same ...

Share via E–mail | Twitter | Facebook

Patent Stock Review Aims to Help Investors Compare IP Companies from ipcloseup.wordpress.com

News aggregator serves up a convenient summary of developments in the public patent space. Patent Stock Review, a news and analysis website started earlier this year, provides easy to access background on a wide range ...

Share via E–mail | Twitter | Facebook

ALJ Gildea Issues Notice Of Initial Determination Finding Violation Of Section 337 By Nanya Technology In Certain Semiconductor Chips With DRAM Circuitry (337-TA-819) from www.itcblog.com

On March 26, 2013, ALJ E. James Gildea issued a notice regarding the Final Initial Determination and Recommended Determination on Remedy and Bond (“ID”) in Certain Semiconductor Chips with DRAM Circuitry, and Modules and Products ...

Share via E–mail | Twitter | Facebook

ALJ Shaw Grants Funai’s Motion For Summary Determination Of Non-Infringement In Certain Audiovisual Components (337-TA-837) from www.itcblog.com

On March 15, 2013, ALJ David P. Shaw issued the public version of Order No. 67 (dated February 27, 2013) granting Respondents Funai Corporation, Inc.; Funai Electric Co., Ltd.; P&F; USA, Inc.; and Funai ...

Share via E–mail | Twitter | Facebook

Australian Pharmaceutical Patents Review’s New Report Critical Of Patent Extensions, R&D Funding from www.ip-watch.org

The Australian Pharmaceutical Patents Review yesterday issued its draft report, recommending that the Australian government reduce pharmaceutical patent extension terms and use estimated savings to subsidise research and development. Related Articles:

Share via E–mail | Twitter | Facebook

Guest Post: New USPTO Professional Conduct Rules Will Take Effect on May 3 from www.patentlyo.com

Guest Post by Lisa Dolak, Angela S. Cooney Professor of Law at Syracuse University College of Law. Professor Dolak has written extensively on professional responsibility issues in the patent law context. Effective May 3, 2013 ...

Share via E–mail | Twitter | Facebook

Piracy a Good Thing for Value? The Game of Thrones. from ipfinance.blogspot.com


George RR Martin’s Game of Thrones is a wildly popular fantasy tale.  The HBO television series Game of Thrones has even eclipsed the popularity of Martin’s books and is apparently the most pirated ...

Share via E–mail | Twitter | Facebook

USPTO Adopts New Ethics Rules Based on ABA Model Rules from www.ipwatchdog.com

The Federal Register Notice explains that currently there are approximately 41,000 registered patent practitioners, with at least 75% of the roster of patent practitioners being attorneys who are admitted in one or more States ...

Share via E–mail | Twitter | Facebook

Registration of security interests: amendment of UK rules from ipfinance.blogspot.com

A recent piece of subordinate legislation in the United Kingdom, the Companies Act 2006 (Amendment of Part 25) Regulations 2013 (SI 2013/600), is not the sort of reading matter that IP enthusiasts would instantly ...

Share via E–mail | Twitter | Facebook

They Invented What? (No. 225) from anticipatethis.wordpress.com

U.S. Patent No. 3,771,192: Combination toy dog and vacuum cleaner. I claim: 1. In combination, a toy animal closely resembling a dog and having a hair covered shell and a hollow interior ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.